Clinical trial

Fluoxetine to Prevent Relapse and Enhance Psychological Recovery in Women With…

NCT00288574 · New York State Psychiatric Institute, Other · Completed

Key facts

NCT number NCT00288574
Title Fluoxetine to Prevent Relapse and Enhance Psychological Recovery in Women With Anorexia Nervosa
Official title Fluoxetine After Weight Restoration in Anorexia Nervosa
Lead sponsor New York State Psychiatric Institute, Other
Collaborators National Institute of Mental Health (NIMH) NIH
Status Completed
Phase Phase 4
Study type Interventional
Conditions Anorexia Nervosa, Eating Disorders
Intervention type Drug
Interventions Fluoxetine, Placebo
Enrollment 93
Start date Jan 1, 2000
Primary completion May 1, 2005
Completion May 1, 2005
First posted Feb 8, 2006
Last update posted Dec 13, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies